CSI Market
Sign In | Register

Bridgebio Oncology Therapeutics Inc (BBOT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BBOT Annual Balance Sheets →
Reviewing balance sheet figures over time helps illustrate how Bridgebio Oncology Therapeutics Inc manages its resources, obligations, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent344.10
Marketable Securities, Current SH290.07
Short-term Investments0.00
Cash & Short-term Investments634.00
Accounts receivable0.66
Other Current Assets0.00
Prepaid Expense And Other Assets Current16.01
Total Current Assets242.38
Equipment/Property/Plant Net0.88
Long-term investments118.42
Other Assets, Noncurrent15.03
Receivables From Related Parties Current-
Operating Lease Right Of Use Asset2.22
Restricted Cash Noncurrent0.13
Total Assets376.71
Liabilities
Accounts Payable, Current AC6.73
Accrued Liabilities, Current6.53
Notes Payable, Current NO0.00
Other Liabilities, Current38.38
Total Current Liabilities51.63
Total Long-term Debt0.00
Other liabilities, Noncurrent1.96
OperatingLeaseLiabilityNoncurrent2.11
Operating Lease Liability Current0.54
Participating Mortgage Loans Participation Liabilities Amount-
Total Liabilities53.59
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock779.19
Retained Earnings / Accumulated Deficit-455.13
Accumulated Other Comprehensive Income-0.96
Other Equity-0.96
Common Stockholder's Equity323.11
Total Stockholder's Equity323.11
Liabilities & Stockholder's Equity376.71
4 historic quarters locked

Sign in to unlock the full Bridgebio Oncology Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Bridgebio Oncology Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-344661

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.